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Connective tissue growth factor (CTGF) is a novel 
peptide that exhibits platelet-derived growth factor-
like activities and is produced by skin fibroblasts after 
activation with transforming growth factor-fl. Coor-
dinate expression of transforming growth factor-J3 
followed by CTGF during wound repair suggests a 
cascade process for control of tissue regeneration. 
We recently reported a significant correlation be-
tween CTGF mRNA expression and histologic scle-
rosis in systemic sclerosis. To confirm the relation 
between CTGF and skin fibrosis, we investigated 
CTGF gene expression in tissue sections fronl pa-
tients with localized scleroderma, keloid, and other 
sclerotic skin disorders using nonradioactive ill sit" 
hybridization. In localized scleroderma, the fibro-
blasts with positive signals for CTGF mRNA were 
scattered throughout the sclerotic lesions with no 
preferential distribution around the inflammatory 
P revious.' in vestigations have revealed in creased produc-tion of collagen and o ther matrix proteins in cultured fibrob lasts fi 'om the afFected skin of systemic o r loca l-ized scleroderma (LeRoy, J 974; Vitto el ti l , 1979; Backingham et til , 1980; Fleischmaje r el til, 1981; Krieg 
el a i , 1983; Kiihari el ti l , 1984; Vuo rio el til, 1985). R ecently, factors 
derived fi'om infiammatOl), ce lls have been suggested to play an 
important ro le in the initia tion of scle roderma. Among these, 
transforming growth factor-(3 (TGF-(3) h 'lS been tocused on be-
ca use it was revealed to stin1l1late collagen and fibronectill produc-
tion by fibrob lasts ;11 1I ;lro (Raghow ci ai , 1987; Varga cl ai, 1987). 
In V ;IIO, overexpression of TGF- (3 has been demonstrated in sys-
terrUc o r localized sclerodenna as well as in eosino philic fascii tis 
(Grusch witz cl til, 1990; Kulozik et tll, 1990; Peltonen el ti l , 1990; 
Peltonen cl til, 1991 b; Gabrielli eI ai, ·1993; Sfikakis cl ai, 1993; 
Higley el ai , J 994). 
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A bbreviation : CTGF, co nl1ective tissue growth fil ctOr. 
cells or perivascular regions, whereas the adjacent 
nonaffected dermis was negative for CTGF mRNA. In 
keloid tissue, the fibroblasts positive for CTGF 
mRNA were diffusely distributed, especially in the 
peripheral expanding lesions. In scar tissue, however, 
the fibroblasts in the fibrotic lesions showed partially 
positive signals for CTGF mRNA. In eosinophilic 
fasciitis, nodular fasciitis, and Dupuytren's contrac-
ture, CTGF mRNA was also expressed partially in the 
fibroblasts of the fibrotic lesions. Our findings rein-
force a correlation between CTGF gene expression 
and skin sclerosis and support the hypothesis that 
transforming growth factor-fl plays an important 
role in the pathogenesis of fibrosis, as it is the only 
inducer for CTGF identified to date. K ey 1V0rds: jib"o-
lIIastsITGF-J3lfillrosislin situ hybridizatiotl. ] It/vest Del'ltla-
tol 106:729-733, 1996 
Overproduction of extracellular ma trix is also prominent in 
keloid ti ssue, which has a genetic predisposi tion and is known to be 
caused by trauma. Kelo id diffe rs from sca rs in that the regeneration 
process does not cease after recovery of the damaged tissue, 
because of the abnormal regulatory pathway of wound healing. 
Enhanced biosyn thes is o f collage ll and fibronectil1 in cultured 
fibrob lasts frol11 keloid tissue has been reported (Diegelmann el til , 
1979; Abergel el ti l, 1985; Babu el ai, 1989) , and TGF-(3 expression 
was also observed in the tissue (Pe ltonen el ti l , 1991a). T hus, it is 
generally agreed that TGF-/3 pl ays a key role in the developm ent of 
these fibrotic skin diseases. 
Connective tissue growth filctor (CTGF) is a cysteine-rich 
peptide, origillall y identified t,'OI11 human umbiLical endothelial 
cells, that exhibits plate let-de ri ved growth factor-Hke activities and 
appears to be antigenically related to pla te le t-derived growth fac tor 
(Bradham el til , 1991) . O ur recent study showed that human 
fo reskin fibroblasts produce high levels of CTGF mRNA and 
protein afte r activation with TG F-(3 (Igarashi cl ai , 1993). In the 
wound chamber model , coordina te TGF- /3 expression fo llowed by 
CTGF in regenerating tissue has been o bserved, suggesting .a 
cascade process fo r the contro l of tissue regeneration and repmr 
(I garashi CI ti l, 1993) . More recently, we reported that CTG.F 
m.RNA is strongly expressed in the fibroblasts located in sclerotIC 
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Figure 1. CTGF mRNA is present in fibroblasts from patients with 
localized scleroderma. T he tissue from patients with localized sclero-
derma was hybridized with CTGF antisense strand probe (A) and sense 
strand probe (8), as described in the text. AlTo",,, in A point to vascular 
endothelial ce ll s negative for CTGF ml~A. 
les.ions 6:om patients with systemic sclerosis, but not in those from 
nomlal controls, inclicating a significant correlation between CTGF 
gene expression and skin sclerosis (Igarashi et ai, 1995) . We 
speculate that CTGF is a candidate autoerine stimulator released in 
response to TGF-{3 in skin fibroblasts and participates in the process 
of skin fibrosis. 
To confirm tlus hypothesis , we examined CTGF gene expression 
in other sclerotic diseases including localized scleroderma, keloid, 
scars, nodular fasciitis, and eosinophil.ic fasciitis by nonradioactive 
;1/. sitll hybridization. CTGF mRNA-positive fibroblasts were dem-
onstrated in these lesions. 
MATElUALS AND METHODS 
Tissue Preparation We evaluated 22 formalin-fixed, paraffin-embed-
ded skin tissues for CTGF m~A expression. These consisted of 12 
localized scleroderma (seven morphea , three generalized morphea, two 
linear sc1erodcnna; mean age 30 y, range 9 -56 y; nlean disease duration 3 
y, range 1 mo to 15 y), three keloid, three scar, one uodular f.1sciitis, one 
eosinophilic f.1sciitis, and two Dupuytren's contracture . Hematoxylin and 
eosin-stained sections of all lesions were reviewed , ,md the respective 
diagnoses were confirnlcd. 
]" Siw Hybridization Formalin-fixed, parafflll-embedded skin tissues 
were investigated lI sing a sLight modification of the nonradioactive ;11 situ 
hybridization procedure using digoxigenin- labeled RNA probes. Briefly, 
paraffin-embedded sections werc cut at a thickness of 4 fLlll , mounted on 
silane-coated slides, deparaffinizcd, and treated with 0.2 M HCI for 15 min, 
then digested w ith t.5 mg/ ml proteinase K for 15 min at 37°C . The sections 
were post-fixed with 4(X( paraformaldehydc in phosphate-bufFered saline and 
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Figure 2. CTGF mRNA is expressed in the sclerotic lesion, but not 
in the adjacent unaffected skin region of localized scleroderma. A. 
same lesion as in B; hematoxylin and eosin-stained section of 10caUzed 
scleroderma biopsy specimen taken from the edge of the lesion . The section 
was hybridized with CTGF antiscnse strand pro be (B). 
soaked in phosphate-bttffered sa linc contaHlJJ1g 2 mg/ml glycine. After 
rinsing with phosphate-buffered salinc, the samples were immersed in 2X 
standard saline citrate buffer (SSC) containing 50% fonnamide and hybrid-
ized. 
Figure 3. No preferential distribution of fibroblasts positive for 
CTGF mRNA in the inflammatory lesion or around the blood 
vessels ill the tissue .from localized sclcrodcrrua. The sect jon was 
hybridized w.ith antisense strand probe. A/TOIIIS indicate the perivascular 
inflammatory cell infiltration . 
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Figure 4. No CTGF gene is expressed in this case of localized 
scleroderma, although histologic sclerosis is apparent. T he section 
was hybridized with CTGF antisense strand probe. 
A 2,100-bp fr:tgmcnt from CTGF cDNA was subcloned into the EcolU 
site of the Bluescript phagemid (Bradham et aI, 1991) and used for making 
probes. Mter linearizing with Xbal, antisense RNA was generated using T3 
RNA polymerase. T7 RNA polymerase allowed the production of a sense 
RNA after li ne:trizing with X I",1. The probes were labeled with digoxige-
nin- ll-UTP using a DIG RNA-labeling kit (Boehringer Mannheim Bio-
chemica, Germany) . The amount of nonradioactive CTGF RNA probes 
was quantifi ed on :t '1 % :tgarose gel and in a dot blot with the labeled control 
RNA using :t DIG nucleic acid detection kit (Boehringer Mannhcim 
Biochemic:t). These riboprobes were tested by Northern blotting; the 
antisense probe recognized the correct mRNA , where:ts the sense probe did 
not give any signals. 
T he labeled RNA probe (final I !kg/ ml), in a mixture containing 50'Yi, 
foonamide, 10% dex tran sul f:lte , I X Dcnhardt's solution, 100 !kg/ Ill I 
tRNA, 5X SSC, 0.25% sodium dodecyl sulf.,te, 1 mM ethylenediamine 
tetraacetic acid , and 50 111M N:t1-l2PO", was placed on the slides and covered 
with a coverslip. Hybridization was performed in a humidified chamber for 
18 h at 45°C, after which the specimens were washed in 2X SSC with 50'Yo 
fonnamide at 50°C. Unhybridizcd probes wcre digested in 2.5 j.Lg/ml 
RNase A, 500 mM NaCI, 1 mM ethylenediamine tetraacetic acid , and 10 
mM Tris HC1, pH 8.0, for 15 min at 37°C. The slides were then washed for 
15 min in 2X SSC and twice in 0.2 X SSC at 50°C. After post-hybridization 
washing, the digoxigenin-labelcd probes were visualized as described in the 
DIG nucleic acid detection kit protocol. The sections were counterstained 
with nuclear fast red. 
Figure 5. Fibroblasts in tbe peripheral lesion ofkcloid tissue strongly 
express CTGF mRNA. The section was hybridized with CTGF antisense 
strand probe. A, cenlnl lesion; D, peliphcral lesion of the keloid tissue . 
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Figure 6. Fibroblasts expressing CTGF mRNA are partially located 
in tbe sclerotic lesion of the scar tissue. The section was hybridized 
with CTGF antisense strand probe. 
RESULTS 
CTGF mRNA Expression in Fibroblasts of Sclerotic Lesions 
Front Localized Scleroderl11a Specimens When tissues liOIn 
12 patients with localized scleroderma were e xamined by ill sil l1 
hybridization with the CTGF antisense strand probe, dermal fibro-
blasts w ith positive signals w ere del1lonstrate d in ten cases . Fibro-
blasts di splaying CTGF mRNA were scattered throughout the 
sclerotic derl1lis , and no preferential accumulation in the p erivas-
cular regions was observed (Fig lA). Dermal vascular endothe lial 
cells were negative for CTGF mRNA. To confirm the specificity of 
the hyblidization with CTG F mRNA, we pe rfo rmed ill sill1 h ybrid-
ization with the CTGF sense strand probe, and no positive signals 
were obtained (Fig 1B). Figure 2A shows a he mato,,:ylin and 
eosin-stain ed section taken from the edge of the mOl'phea, which 
shows scle roti c changes in the right upper portion and a n o rmal 
region in the le ft lower portion. As shown in Fig 2B, the fibroblasts 
with positive signals were distributed in the sclero ti c ti ssue, whereas 
no hybrid.ization was observed in the adjacent un affected region. 
Nonspecific background staining was observed in the eccrine sweat 
glands. In one case that showed pronounced inflammato ry cell 
infiltration , CTG F mRNA expression was mode rate and no pref-
erential distribution was observed around the inflammatOl'y foci 
(Fig 3). In two cases , virtua lly no CTGF gene expression was 
detected, although histologic sclerosis was apparent (Fig 4). 
Differential Expression of CTGF mRNA in Keloid and 
Other Sclerotic Skin Diseases Next, we investigated CTGF 
gene expression in keloid, scars, and other fibroti c skin disorders. In 
keloid tissue , the fibroblasts with positive h ybridization signals 
w ere distributed throughout the les ions, especially in the peripheral 
areas (Fig 5). In scar tissue, CTGF mRNA was parLial1y expressed 
in the fibroblasts of the lesion , although CTGF mRNA-negative 
lesions were also observed il1 the fibroti c Lissue (Fig 6), as seen in 
nodular fasciiti s. In eo sinophilic fa sc ii tis, fibrobla sts located in the 
thickened f.~scia also expressed CTGF mRNA (data not shown) . Of 
the two cases of Dupuytre n 's contracture, one specin1en gave 
posi tive signals for CTGF mRNA in the fibroblasts of the fibrotic 
les ions, whe reas the other sample revealed negative h ybridization 
(data not shown). 
The results of the above experiments are suml11alized in Table I. 
DISCUSSION 
CTGF has platelet-derived growth factor-like biolog ic activity and 
is secreted fi'om human umbilical endothelia l cells (Bradham ef nl, 
1991) , as w ell as from human foreskin fibroblasts after acLivation 
with TGF- (3 ill Il ifro (Igarashi ct aI, 1993). CTGF is a m ember of a 
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Table I. CTGF mRNA Expression in Sclerotic Disorders" 
D isease 
Morphea 
Generali zed m o rphea 













I I I 
112 
" Pnralli ll -c l1Ibcddcd ~ccl io ll S were hyhridized w ith CTCF antisense strand probe. 
and the sig"nls were visualized I1S mentioned in the text. 
" Positive/number or cases exami ned. The case that had apparent purple-stained 
p~lrLicJc s W;\S ocflll cd ;IS positive. 
fam ily of peptides that includes the v-src-induced CEF-I0 peptide, 
identified in src-tran sformed chicken embryo fibrob lasts (Simmons 
cl ai, 1989), c)'r61 cloned from mouse BALB/c 3T3 fibro blasts afte r 
serum induction (O'Brien 1'1 ai, 1990), and the serum-induced./isp12 
(Ryseck el ai, 1991) or TGF-{3-illdu ced {3JGJ\!I2 transc l'ip t identified 
in 3T3 cells (Brunner cl ai, 1991). CTGF is also related to the 1/0/1 
genc product, which is overexpressed in nephroblastomas induced 
by m ycloblastos is-associated virus Uoliot c/ ai, 1992). Among 
CTGF-rclated gencs, cxprcssion of Cj'r61 was reported to be 
correlated with chondrogcnesis during cmbryon ic devclopment 
(O'Bricn and Lau, 1992) , yet the biologic roles of thesc CTGP-
re lated gcne products arc poorly undcrstood , 
We ha ve recently rcported that dermal fibroblasts of system ic 
sclcrosis were posit ive for CTGF mRNA in all cascs that showed 
histologic scle rosis. Fibrob lasts with positivc hybridization signal s 
were morc abundan t in the tissue /Tom the sclerotic stage th an in 
that from the inAammatory stagc, indi cating a closc corrc la tion 
between CTGF gene ",xprcss ion and fibrosis (Igarashi e/ ai, 1995). 
In localizcd sclerodcrma, thc fibroblasts with positi ve hybridiza-
tion for CTGF mRNA ex press ion were also scattered in the 
sclerotic lesions of the tisslle . This observation is basically consistent 
with that in systcm ic sclerosis, altho ugh thc leve l of gcnc ex prcssion 
differed in each case examincd and was not correlated c losely with 
the hi stologic sclerosis, as observed in systcmic sclerosis. In systemic 
scl",rosis, it is well known that the sclerotic les ions diminish 
spontan eously durin g the d isease process whcn they reach the 
atrophic stagc. It is likely that extraccllul ar matrix syn thes is and 
dcgradation procecd simultaneously in systemic sclerosis; enhanced 
biosynth",sis cxcecds the rate of d"'gradation at thc sclcrotic stage, 
but when the disease reaches the atrophic stage, the fibroblasts lose 
their activities and dcgradation prcdominates , rcsulting in the 
disappcarance of skin fibrosis. Thesc aspccts can explain the close 
co rrdation between CTGF mRNA cxprcssion and histologic scle-
rosis in systemic sclerosis. In loca li zcd scl"'rodcrma, howevcr, the 
extracellular matrix degradation process seems to bc diffcrent fi~om 
that in systcmic sclerosis , T his is why histologic sclcrosis was still 
obvious although the CTGF gene was no longer expressed in somc 
cascs of loca lized sclc rodcrma obscrved in this study. T hus, we 
speculate that the level of CTGF mR.NA express ion is correlated 
with the activity of fibroblasts. Our examination of kcloid tisslle 
and scars supports thi s spccu lation. CTGF cxprcssion was pro-
noun ced in ke lo id , especiall y in the expanding borde r of the 
les ions. In scars, however, CTG lo gene expression was partially 
positive; thc rc was on", fibrotic lesion in w hich no CTGF mH.NA 
was expressed, indicating that diseasc activi ty was already d imin-
ished. These observations also suppo rt the hypothesis that CTGF is 
a poten tia l <Iutocri nc stimulator re leased in response to TGF-{3 in 
skin fibrob lasts, "nd participa tes in the process of tiss ll e regenera-
tion and skin fibrosis. 
It rcmains unc lear, howcver, w hy thc CTGF gcne is cxpresscd 
continuously in the les ions, despite the proposcd ro le ofTGF- {3 in 
initiation of the disease process. Two possibilities can be postula ted: 
(i) Unknown factor(s) i ll I/iI", may function to maintain CTC F gcnc 
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cxpression; o r (ii) the fibrob lasts of thc affected lesions already 
eludc the normal TGF-/3 rcgulatol'y prognllrl in the very earliest 
stagc of the discasc and maintain CTCF production. A ltered 
responses to TGF-{3 in fibrobla sts derived from kc lo id or localized 
sclcroderma have bcen reported (Babu el ai, 1992). T he latter 
poss ibi li ty is thus the more like ly explanation. 
T he regulation processes of CTGF, co ll agcn, and fib ronectin 
gene expression are similar because thesc genes are induced by 
TGF-{3 and expressed in fibroti c skin tiss uc. It remains unknown, 
and should be targeted for furthc r investigation , whcther CTGF is 
m crely expressed simul taneously or interacts w ith the metabolism 
of these matrix proteins. 
In conclusion, CTGF genc expression was demonstrated in 
severa l fibroti c skin diseases, suggesting a pathogcnic role for tillS 
molccuic in skin fibrosis. 
This "'''rk Ilas slIpported b}' n srmll -i ll -n it! Jim" the i\llill is/f)' (!f EdIlCt"iOIl, ScifllCC, 
ami C Hltllrc f!/"japIIII, mill by n .l!f(l/ I/ Ji,,. basir dcnlltZl%gic resenrch Ji oolll Siliscido 
Co., LTd. 
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